"With funding from AstraZeneca, the American Cancer Society Patient Navigator Program will enable us to assist patients with personalized community resources and support," said Richard G. Pestell, M.D., Ph.D., director, Kimmel Cancer Center at Jefferson. "This program proactively reaches patients who are most in need of specialized services and support, providing the critical link to local resources that will improve their outcomes and quality of life."
As no cancer experience is the same, American Cancer Society patient navigators connect patients and caregivers with the most appropriate programs and services to help improve each individual's access to health care and quality of life. Whether it is getting patients and caregivers the information they need to make treatment decisions and better understand their disease, helping them deal with the day-to-day challenges of living with cancer, such as transportation and insurance issues, or connecting them with community resources such as support groups, American Cancer Society patient navigators can provide help throughout the disease continuum -- from the time of diagnosis, through treatment, into survivorship. Furthermore, navigators are able to increase treatment compliance and follow-up care.
"AstraZeneca is thrilled to be the first company to give nationwide, large-scale support to the American Cancer Society Patient Navigator Program," said Lisa Schoenberg, Vice President of Growth Specialty Care, AstraZeneca Pharmaceuticals LP. "This new program site at Jefferson is a testament to our commitment to help provide cancer patients with personalized cancer care. We are proud to support the American Cancer Society Patient Navigator Program in its mission to improve patient outcomes, not only in Philadelp
Copyright©2009 PR Newswire.
All rights reserved